FDA Clears IMRIS' VISIUS Surgical Theatre Imaging System

Minnetonka, Minn.-based IMRIS received clearance from the U.S. Food and Drug Administration for the next generation of its VISIUS Surgical Theatre, an intraoperative imaging system.

VISIUS Surgical Theatre is a transportable magnetic resonance and computed tomography imaging system. Surgeons can request the system be brought to the operating room if necessary during a procedure, eliminating the need to move the patient for imaging and reducing the risk of patient harm, according to IMRIS' website.

This latest generation that received FDA clearance integrates Munich, Bavaria-based Siemens' latest MR scanners and will "deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition and improved ease of use and workflow during neurosurgical procedures using intraoperative MRI," according to the news release.

More Articles on FDA Cleared Devices:

FDA Clears Given Imaging's PillCam COLON for Incomplete Colonoscopies
Sofosbuvir Earns FDA Approval as Hepatitis C Treatment
FDA Approves Medtronic's CoreValve Transcatheter Without Panel Review

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars